SOURCE: Xtalks

Xtalks Webinars

September 14, 2015 15:00 ET

Top News Stories You Might Have Missed From Xtalks. Xtalks Provides Daily News in the Life Science Industry

TORONTO, ON--(Marketwired - September 14, 2015) -

Check out all our news stories here:

Accurate Blood Test Could Become Standard For Cancer Diagnosis -
(Sep 14) Researchers in the UK have developed a novel blood test to detect cancer, which could replace costly, time-consuming biopsy diagnostic methods.

Drug Adherence Device Developed By Proteus and Otsuka, Awaits FDA Approval -
(Sep 14) Otsuka and Proteus Digital Health have developed a drug adherence combo device to monitor how patients are taking their medications.

Aspen Pharmacare Seeks International Acquisitions -
(Sep 11) South Africa's largest generic drugs manufacturer -- Aspen Pharmacare Holdings Ltd. -- is actively seeking overseas acquisitions in an effort to expand its infant nutrition business.

Potential Migraine Biomarker Found in the Blood -
(Sep 11) A team of researchers at Johns Hopkins University School of Medicine in Maryland, have identified a biomarker that may help doctors diagnose and treat patients suffering from episodic migraines.

Biodegradable Implant Reduces Cancer Metastasis -
(Sep 10) Researchers at Northwestern University Feinberg School of Medicine in Illinois, have developed a novel implant capable of capturing cancer cells travelling through the body, in order to reduce metastasis.

Wearable and Ingestible Devices to Be Developed by Biogen -
(Sep 10) According to an interview with The Wall Street Journal, the Biogen CEO wants to break into the wearable space.

FDA Approves Drug to Prevent Chemotherapy-Induced Nausea and Vomiting -
(Sep 9) The FDA has approved the antiemetic drug Varubi (rolapitant), for the prevention of nausea and vomiting associated with chemotherapy treatment.

US-Based AqueSys to Be Bought By Irish Company Allergan -
(Sep 9) The Ireland-based pharmaceutical company Allergan, has agreed to acquire the medical device company AqueSys, for $300 million.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Contact Information